New York City-based Oliver Wyman released findings on private equity deals in healthcare based on data from the first half of 2022.
Becker’s identified five takeaways from the report. The top two:
- The amount of private, capital-backed healthcare deals has significantly declined.
- There has been a higher level of capital invested in 2022 so far, mainly because of Bain Capital and Hellman & Friedman’s $17 billion buyout of health tech company Athenahealth in the first quarter. Read more.
